Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

ABUS – Arbutus Biopharma Corporation

Arbutus Biopharma Corporation
ABUS
$3.48
Name : Arbutus Biopharma Corporation
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $666,513,984.00
EPSttm : -0.41
finviz dynamic chart for ABUS
Arbutus Biopharma Corporation
$3.48
2.35%
$0.08

Float Short %

7.74

Margin Of Safety %

Put/Call OI Ratio

0.25

EPS Next Q Diff

0.05

EPS Last/This Y

-0.05

EPS This/Next Y

0.06

Price

3.48

Target Price

5.25

Analyst Recom

1.5

Performance Q

5.14

Relative Volume

0.57

Beta

1.24

Ticker: ABUS




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-05-08ABUS3.290.260.9132245
2025-05-09ABUS3.220.260.0732228
2025-05-12ABUS3.350.260.0032180
2025-05-13ABUS3.180.250.0932903
2025-05-14ABUS3.160.250.1333288
2025-05-15ABUS3.120.250.0533540
2025-05-16ABUS3.080.250.0033571
2025-05-19ABUS3.120.260.0032098
2025-05-20ABUS3.210.260.2932328
2025-05-21ABUS3.170.260.0337179
2025-05-22ABUS3.20.260.2637226
2025-05-23ABUS3.210.260.0037237
2025-05-27ABUS3.440.260.0037248
2025-05-28ABUS3.410.260.0037316
2025-05-29ABUS3.430.260.0037758
2025-05-30ABUS3.350.260.0037989
2025-06-02ABUS3.350.260.0038017
2025-06-03ABUS3.440.250.0338091
2025-06-04ABUS3.410.250.0038147
2025-06-05ABUS3.40.250.0038264
2025-06-06ABUS3.470.250.0038493
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-05-08ABUS3.29-11.7- -0.33
2025-05-09ABUS3.22-11.7- -0.33
2025-05-12ABUS3.35-11.7- -0.33
2025-05-13ABUS3.18-11.7- -0.33
2025-05-14ABUS3.16-11.7- -0.33
2025-05-15ABUS3.1262.4- -0.33
2025-05-16ABUS3.0862.4- -0.33
2025-05-19ABUS3.1335.7- -0.45
2025-05-20ABUS3.2140.3- -0.43
2025-05-21ABUS3.1740.3- -0.43
2025-05-22ABUS3.2040.3- -0.43
2025-05-23ABUS3.2140.3- -0.43
2025-05-27ABUS3.4540.3- -0.43
2025-05-28ABUS3.4140.3- -0.43
2025-05-29ABUS3.4340.3- -0.43
2025-05-30ABUS3.3640.3- -0.43
2025-06-02ABUS3.3540.3- -0.43
2025-06-03ABUS3.4540.3- -0.43
2025-06-04ABUS3.4140.3- -0.43
2025-06-05ABUS3.4040.3- -0.43
2025-06-06ABUS3.4840.3- -0.43
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-05-08ABUS-0.182.687.44
2025-05-09ABUS-0.182.687.44
2025-05-12ABUS-0.181.507.53
2025-05-13ABUS-0.181.507.53
2025-05-14ABUS-0.181.507.53
2025-05-15ABUS-0.181.507.53
2025-05-16ABUS-0.181.507.53
2025-05-19ABUS-0.182.047.53
2025-05-20ABUS-0.182.047.53
2025-05-21ABUS-0.182.047.53
2025-05-22ABUS-0.182.047.53
2025-05-23ABUS-0.182.047.53
2025-05-27ABUS-0.188.777.53
2025-05-28ABUS-0.188.777.74
2025-05-29ABUS-0.188.777.74
2025-05-30ABUS-0.188.777.74
2025-06-02ABUS-0.189.177.74
2025-06-03ABUS-0.189.177.74
2025-06-04ABUS-0.189.177.74
2025-06-05ABUS-0.189.177.74
2025-06-06ABUS-0.189.177.74
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-0.13

Avg. EPS Est. Current Quarter

-0.09

Avg. EPS Est. Next Quarter

-0.08

Insider Transactions

-0.18

Institutional Transactions

9.17

Beta

1.24

Average Sales Estimate Current Quarter

2

Average Sales Estimate Next Quarter

2

Fair Value

Quality Score

25

Growth Score

28

Sentiment Score

35

Actual DrawDown %

61.4

Max Drawdown 5-Year %

-72.7

Target Price

5.25

P/E

Forward P/E

PEG

P/S

104.14

P/B

8.42

P/Free Cash Flow

EPS

-0.4

Average EPS Est. Cur. Y​

-0.43

EPS Next Y. (Est.)

-0.38

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-1195.86

Relative Volume

0.57

Return on Equity vs Sector %

-120.8

Return on Equity vs Industry %

-102.8

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.11

EBIT Estimation

Arbutus Biopharma Corporation
Sector: Healthcare
Industry: Biotechnology
Employees: 44
Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus product pipeline comprises Imdusiran, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic product candidate which is in phase 1 and phase 2a clinical trials that suppresses all HBV antigens, including HBsAg expression; and AB-101, an oral PD-L1 inhibitor, which is in phase 1a/1b clinical trial that has the potential to reawaken patients' HBV-specific immune response by inhibiting PD-L1. The company has licensing agreement with Alnylam Pharmaceuticals, Inc. to develop and commercialize products with LNP delivery technology. The company was formerly known as Tekmira Pharmaceuticals Corporation and changed its name to Arbutus Biopharma Corporation in July 2015. Arbutus Biopharma Corporation was incorporated in 2005 is headquartered in Warminster, Pennsylvania.
stock quote shares ABUS – Arbutus Biopharma Corporation Stock Price stock today
news today ABUS – Arbutus Biopharma Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch ABUS – Arbutus Biopharma Corporation yahoo finance google finance
stock history ABUS – Arbutus Biopharma Corporation invest stock market
stock prices ABUS premarket after hours
ticker ABUS fair value insiders trading

ABUS – Arbutus Biopharma Corporation

Arbutus Biopharma Corporation
ABUS
$3.48
Name : Arbutus Biopharma Corporation
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $666,513,984.00
EPSttm : -0.41
finviz dynamic chart for ABUS
Arbutus Biopharma Corporation
$3.48
2.35%
$0.08

Float Short %

7.74

Margin Of Safety %

Put/Call OI Ratio

0.25

EPS Next Q Diff

0.05

EPS Last/This Y

-0.05

EPS This/Next Y

0.06

Price

3.48

Target Price

5.25

Analyst Recom

1.5

Performance Q

5.14

Relative Volume

0.57

Beta

1.24

Ticker: ABUS




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-05-08ABUS3.290.260.9132245
2025-05-09ABUS3.220.260.0732228
2025-05-12ABUS3.350.260.0032180
2025-05-13ABUS3.180.250.0932903
2025-05-14ABUS3.160.250.1333288
2025-05-15ABUS3.120.250.0533540
2025-05-16ABUS3.080.250.0033571
2025-05-19ABUS3.120.260.0032098
2025-05-20ABUS3.210.260.2932328
2025-05-21ABUS3.170.260.0337179
2025-05-22ABUS3.20.260.2637226
2025-05-23ABUS3.210.260.0037237
2025-05-27ABUS3.440.260.0037248
2025-05-28ABUS3.410.260.0037316
2025-05-29ABUS3.430.260.0037758
2025-05-30ABUS3.350.260.0037989
2025-06-02ABUS3.350.260.0038017
2025-06-03ABUS3.440.250.0338091
2025-06-04ABUS3.410.250.0038147
2025-06-05ABUS3.40.250.0038264
2025-06-06ABUS3.470.250.0038493
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-05-08ABUS3.29-11.7- -0.33
2025-05-09ABUS3.22-11.7- -0.33
2025-05-12ABUS3.35-11.7- -0.33
2025-05-13ABUS3.18-11.7- -0.33
2025-05-14ABUS3.16-11.7- -0.33
2025-05-15ABUS3.1262.4- -0.33
2025-05-16ABUS3.0862.4- -0.33
2025-05-19ABUS3.1335.7- -0.45
2025-05-20ABUS3.2140.3- -0.43
2025-05-21ABUS3.1740.3- -0.43
2025-05-22ABUS3.2040.3- -0.43
2025-05-23ABUS3.2140.3- -0.43
2025-05-27ABUS3.4540.3- -0.43
2025-05-28ABUS3.4140.3- -0.43
2025-05-29ABUS3.4340.3- -0.43
2025-05-30ABUS3.3640.3- -0.43
2025-06-02ABUS3.3540.3- -0.43
2025-06-03ABUS3.4540.3- -0.43
2025-06-04ABUS3.4140.3- -0.43
2025-06-05ABUS3.4040.3- -0.43
2025-06-06ABUS3.4840.3- -0.43
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-05-08ABUS-0.182.687.44
2025-05-09ABUS-0.182.687.44
2025-05-12ABUS-0.181.507.53
2025-05-13ABUS-0.181.507.53
2025-05-14ABUS-0.181.507.53
2025-05-15ABUS-0.181.507.53
2025-05-16ABUS-0.181.507.53
2025-05-19ABUS-0.182.047.53
2025-05-20ABUS-0.182.047.53
2025-05-21ABUS-0.182.047.53
2025-05-22ABUS-0.182.047.53
2025-05-23ABUS-0.182.047.53
2025-05-27ABUS-0.188.777.53
2025-05-28ABUS-0.188.777.74
2025-05-29ABUS-0.188.777.74
2025-05-30ABUS-0.188.777.74
2025-06-02ABUS-0.189.177.74
2025-06-03ABUS-0.189.177.74
2025-06-04ABUS-0.189.177.74
2025-06-05ABUS-0.189.177.74
2025-06-06ABUS-0.189.177.74
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-0.13

Avg. EPS Est. Current Quarter

-0.09

Avg. EPS Est. Next Quarter

-0.08

Insider Transactions

-0.18

Institutional Transactions

9.17

Beta

1.24

Average Sales Estimate Current Quarter

2

Average Sales Estimate Next Quarter

2

Fair Value

Quality Score

25

Growth Score

28

Sentiment Score

35

Actual DrawDown %

61.4

Max Drawdown 5-Year %

-72.7

Target Price

5.25

P/E

Forward P/E

PEG

P/S

104.14

P/B

8.42

P/Free Cash Flow

EPS

-0.4

Average EPS Est. Cur. Y​

-0.43

EPS Next Y. (Est.)

-0.38

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-1195.86

Relative Volume

0.57

Return on Equity vs Sector %

-120.8

Return on Equity vs Industry %

-102.8

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.11

EBIT Estimation

Arbutus Biopharma Corporation
Sector: Healthcare
Industry: Biotechnology
Employees: 44
Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus product pipeline comprises Imdusiran, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic product candidate which is in phase 1 and phase 2a clinical trials that suppresses all HBV antigens, including HBsAg expression; and AB-101, an oral PD-L1 inhibitor, which is in phase 1a/1b clinical trial that has the potential to reawaken patients' HBV-specific immune response by inhibiting PD-L1. The company has licensing agreement with Alnylam Pharmaceuticals, Inc. to develop and commercialize products with LNP delivery technology. The company was formerly known as Tekmira Pharmaceuticals Corporation and changed its name to Arbutus Biopharma Corporation in July 2015. Arbutus Biopharma Corporation was incorporated in 2005 is headquartered in Warminster, Pennsylvania.
stock quote shares ABUS – Arbutus Biopharma Corporation Stock Price stock today
news today ABUS – Arbutus Biopharma Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch ABUS – Arbutus Biopharma Corporation yahoo finance google finance
stock history ABUS – Arbutus Biopharma Corporation invest stock market
stock prices ABUS premarket after hours
ticker ABUS fair value insiders trading